This analysis demonstrates the prognostic significance of residual T and N status after neoadjuvant therapy in breast cancer, suggesting better treatment planning.
Residual T and N positivity after NST represents a simple yet powerful prognostic indicator in breast cancer. This two-factor classification, easily derived from routine pathology, may serve as a practical reference for post-NST risk stratification and inform decisions regarding additional adjuvant treatment.
No takes yet. Share an insight, caveat, or question.
FUJIOKA et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: